Search Results - "Hobbing, Katharine R."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis by Schmidt, M Lee, Hobbing, Katharine R, Donninger, Howard, Clark, Geoffrey J

    Published in Cancer research (Chicago, Ill.) (15-05-2018)
    “…Mutant K-RAS has been shown to have both tumor-promoting and -suppressing functions, and growing evidence suggests that the RASSF family of tumor suppressors…”
    Get full text
    Journal Article
  2. 2

    Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells by Jones, Dominique Z, Schmidt, M Lee, Suman, Suman, Hobbing, Katharine R, Barve, Shirish S, Gobejishvili, Leila, Brock, Guy, Klinge, Carolyn M, Rai, Shesh N, Park, Jong, Clark, Geoffrey J, Agarwal, Rajesh, Kidd, LaCreis R

    Published in BMC cancer (13-04-2018)
    “…Dysregulation of microRNA (miRNA) expression is associated with hallmarks of aggressive tumor phenotypes, e.g., enhanced cell growth, proliferation, invasion,…”
    Get full text
    Journal Article
  3. 3

    The RASSF1A Tumor Suppressor Regulates XPA-Mediated DNA Repair by Donninger, Howard, Clark, Jennifer, Rinaldo, Francesca, Nelson, Nicholas, Barnoud, Thibaut, Schmidt, M. Lee, Hobbing, Katharine R., Vos, Michele D., Sils, Brian, Clark, Geoffrey J.

    Published in Molecular and cellular biology (01-01-2015)
    “…RASSF1A may be the most frequently inactivated tumor suppressor identified in human cancer so far. It is a proapoptotic Ras effector and plays an important…”
    Get full text
    Journal Article
  4. 4

    Abstract 1906: Inhibition of miR-186 and repression of aggressive prostate cancer phenotype using a metastatic cell model by Jones, Dominique Z., Schmidt, M. Lee, Hobbing, Katharine R., Clark, Geoffrey, Kidd, LaCreis R.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…MicroRNA (miR) dysregulation alters the expression of cancer related genes and contributes to disease states in many cancers. For example, ectopic miR-186…”
    Get full text
    Journal Article
  5. 5

    miR‐186 suppresses cell proliferation and anchorage‐independence in a metastatic prostate cancer cell line by Jones, Dominique Z., Schmidt, M. Lee, Hobbing, Katharine R., Clark, Geoffrey, Kidd, LaCreis R.

    Published in The FASEB journal (01-04-2016)
    “…Abstract only MicroRNA (miR) dysregulation alters the expression of cancer related genes and contributes to disease states in many cancers. For example,…”
    Get full text
    Journal Article
  6. 6

    Suppression of miR‐186 Attenuates Cellular Invasion, pAKT and β‐catenin in Metastatic Prostate Cancer Cell Models by Jones, Dominique, Suman, Suman Renee, Schmidt, M. Lee, Hobbing, Katharine R, Barve, Shirish, Gobejishvili, Leila, Klinge, Carolyn, Rai, Shesh, Clark, Geoffrey, Brock, Guy, Agarwal, Rajesh, Kidd, LaCreis Renee

    Published in The FASEB journal (01-04-2018)
    “…Background MicroRNA (miR) dysregulation alters the expression of cancer related genes and contributes to disease states in many cancers. For example, ectopic…”
    Get full text
    Journal Article
  7. 7

    Abstract 3085: MicroRNA-186 inhibition alters cell proliferation and colony formation in prostate cancer by Jones, Dominique Zilpha, Hobbing, Katharine R., Schmidt, M. L., Clark, Geoffrey J., Kidd, LaCreis R.

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…MicroRNAs (miRs), key regulators of cancer-related genes, are dysregulated in many solid tumors, including prostate cancer. However, the role of miR-186 in…”
    Get full text
    Journal Article